These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1467 related articles for article (PubMed ID: 16020737)

  • 1. Tau suppression in a neurodegenerative mouse model improves memory function.
    Santacruz K; Lewis J; Spires T; Paulson J; Kotilinek L; Ingelsson M; Guimaraes A; DeTure M; Ramsden M; McGowan E; Forster C; Yue M; Orne J; Janus C; Mariash A; Kuskowski M; Hyman B; Hutton M; Ashe KH
    Science; 2005 Jul; 309(5733):476-81. PubMed ID: 16020737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau.
    Tanemura K; Murayama M; Akagi T; Hashikawa T; Tominaga T; Ichikawa M; Yamaguchi H; Takashima A
    J Neurosci; 2002 Jan; 22(1):133-41. PubMed ID: 11756496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.
    Tanemura K; Akagi T; Murayama M; Kikuchi N; Murayama O; Hashikawa T; Yoshiike Y; Park JM; Matsuda K; Nakao S; Sun X; Sato S; Yamaguchi H; Takashima A
    Neurobiol Dis; 2001 Dec; 8(6):1036-45. PubMed ID: 11741399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
    Fox LM; William CM; Adamowicz DH; Pitstick R; Carlson GA; Spires-Jones TL; Hyman BT
    J Neuropathol Exp Neurol; 2011 Jul; 70(7):588-95. PubMed ID: 21666499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
    Hochgräfe K; Sydow A; Mandelkow EM
    FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
    Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
    Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.
    Van der Jeugd A; Hochgräfe K; Ahmed T; Decker JM; Sydow A; Hofmann A; Wu D; Messing L; Balschun D; D'Hooge R; Mandelkow EM
    Acta Neuropathol; 2012 Jun; 123(6):787-805. PubMed ID: 22532069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
    Ramsden M; Kotilinek L; Forster C; Paulson J; McGowan E; SantaCruz K; Guimaraes A; Yue M; Lewis J; Carlson G; Hutton M; Ashe KH
    J Neurosci; 2005 Nov; 25(46):10637-47. PubMed ID: 16291936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of tau in the development of Alzheimer's disease].
    Takashima A
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.
    Zhang Z; Song M; Liu X; Kang SS; Kwon IS; Duong DM; Seyfried NT; Hu WT; Liu Z; Wang JZ; Cheng L; Sun YE; Yu SP; Levey AI; Ye K
    Nat Med; 2014 Nov; 20(11):1254-62. PubMed ID: 25326800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
    Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
    Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for tau in learning, memory and synaptic plasticity.
    Biundo F; Del Prete D; Zhang H; Arancio O; D'Adamio L
    Sci Rep; 2018 Feb; 8(1):3184. PubMed ID: 29453339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent phosphorylation pattern of tau in P301L tau transgenic mice.
    Deters N; Ittner LM; Götz J
    Eur J Neurosci; 2008 Jul; 28(1):137-47. PubMed ID: 18662339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic loss.
    Kimura T; Fukuda T; Sahara N; Yamashita S; Murayama M; Mizoroki T; Yoshiike Y; Lee B; Sotiropoulos I; Maeda S; Takashima A
    J Biol Chem; 2010 Dec; 285(49):38692-9. PubMed ID: 20921222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?
    Belarbi K; Burnouf S; Fernandez-Gomez FJ; Desmercières J; Troquier L; Brouillette J; Tsambou L; Grosjean ME; Caillierez R; Demeyer D; Hamdane M; Schindowski K; Blum D; Buée L
    Curr Alzheimer Res; 2011 Sep; 8(6):633-8. PubMed ID: 21605043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
    Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
    J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.